dc.contributor.author |
David, Valeriu |
|
dc.contributor.author |
Petrovici, Vergil |
|
dc.contributor.author |
Saptefrati, Lilian |
|
dc.contributor.author |
Fulga, Veaceslav |
|
dc.contributor.author |
Carpenco, Ecaterina |
|
dc.contributor.author |
Frant, Elena |
|
dc.date.accessioned |
2023-01-28T12:16:40Z |
|
dc.date.available |
2023-01-28T12:16:40Z |
|
dc.date.issued |
2022 |
|
dc.identifier.citation |
DAVID, Valeriu, PETROVICI, Vergil, SAPTEFRATI, Lilian, et al. Evaluation of p57 expression in early disordered pregnancies with molar status vs non-molar ones. In: The Moldovan Medical Journal. 2022, vol. 65, no 2, pp. 33-36. ISSN 2537-6381. https://doi.org/10.52418/moldovan-med-j.65-2.22.01 |
en_US |
dc.identifier.issn |
2537-6373 |
|
dc.identifier.issn |
2537-6381 |
|
dc.identifier.uri |
https://moldmedjournal.md/wp-content/uploads/2022/12/02-Moldovan-Med-J-2022-Vol65-No2.pdf |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/23608 |
|
dc.description.abstract |
Background: The molar and non-molar lesions are determined during histomorphological examination and treated as inconclusive. The establishing
of a marker by immunohistochemical investigations could influence the accuracy of the morphopathological diagnosis. The aim is evaluation of p57
immunoexpression in the trophoblastic germ compartment in molar and non-molar pregnancies.
Material and methods: Abortion products from 15 patients with hydatidiform mole, 18 pregnancies solved on social indications and 16 short-term
disordered pregnancies were evaluated depending on the immunoexpresion of p57.
Results: The hydatidiform mole was classified based on anti-p57 immunoexpression into: complete hydatidiform mole – 8 cases (negative immunoexpression
or expression in ˂10% of villous cytotrophoblast) and partial hydatidiform mole – 7 cases (positive expression in ˃10% of the villous cytotrophoblast).
Basal deciduous and extravillous cytotrophoblasts were positive in 100% of cases and served as internal control. Hepatocytes were used as negative control.
In the control group, the positive immunoexpression was attested in >10% of cases in the villous trophoblast.
Conclusions: Differential immunoexpression of p57 protein in the germinal cytotrophoblast allows subclassification of molar pathology into complete
and partial forms, while not allowing the differentiation between partial hydatidiform mole and non-molar lesions. Immunohistochemical evaluation of
p57kip2 protein in molar and non-molar pathology is useful in differential diagnosis as a complementary method. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
The Scientific Medical Association of the Republic of Moldova |
en_US |
dc.relation.ispartof |
The Moldovan Medical Journal |
en_US |
dc.subject |
anti-p57 |
en_US |
dc.subject |
fetal concept |
en_US |
dc.subject |
hydatidiform mole |
en_US |
dc.subject |
trophoblastic disease |
en_US |
dc.subject.ddc |
UDC: 618.32+611.013 |
en_US |
dc.title |
Evaluation of p57 expression in early disordered pregnancies with molar status vs non-molar ones |
en_US |
dc.type |
Article |
en_US |